In the HCV disease models, it was demonstrated that despite the expression of viral entry factors such as human Occludin (OCLN) [77] and CD81 [78,79] in transgenic C57BL/6 mice, in vivo infection with HCV was restricted [80]. The gene discussed is OCLN; the disease is infection.